nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP2A6—Methoxsalen—psoriasis	0.0686	0.0981	CbGbCtD
Ifosfamide—CYP2C8—Tazarotene—psoriasis	0.0525	0.0751	CbGbCtD
Ifosfamide—CYP3A5—Beclomethasone—psoriasis	0.0507	0.0726	CbGbCtD
Ifosfamide—CYP2A6—Prednisolone—psoriasis	0.0333	0.0477	CbGbCtD
Ifosfamide—CYP2B6—Cholecalciferol—psoriasis	0.0296	0.0423	CbGbCtD
Ifosfamide—CYP2C8—Cholecalciferol—psoriasis	0.0224	0.0321	CbGbCtD
Ifosfamide—CYP3A7—Hydrocortisone—psoriasis	0.0216	0.0309	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0216	0.0309	CbGbCtD
Ifosfamide—CYP3A7—Cyclosporine—psoriasis	0.0204	0.0292	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0204	0.0292	CbGbCtD
Ifosfamide—CYP3A5—Mycophenolate mofetil—psoriasis	0.0202	0.0289	CbGbCtD
Ifosfamide—CYP2A6—Dexamethasone—psoriasis	0.0197	0.0281	CbGbCtD
Ifosfamide—CYP2C8—Mycophenolate mofetil—psoriasis	0.0194	0.0278	CbGbCtD
Ifosfamide—CYP2C19—Cholecalciferol—psoriasis	0.0188	0.0269	CbGbCtD
Ifosfamide—CYP3A4—Calcitriol—psoriasis	0.0176	0.0252	CbGbCtD
Ifosfamide—CYP3A5—Hydrocortisone—psoriasis	0.0162	0.0232	CbGbCtD
Ifosfamide—CYP2C9—Cholecalciferol—psoriasis	0.0156	0.0224	CbGbCtD
Ifosfamide—CYP2C8—Hydrocortisone—psoriasis	0.0156	0.0223	CbGbCtD
Ifosfamide—CYP3A5—Cyclosporine—psoriasis	0.0153	0.0219	CbGbCtD
Ifosfamide—CYP2C8—Cyclosporine—psoriasis	0.0147	0.0211	CbGbCtD
Ifosfamide—CYP3A4—Methoxsalen—psoriasis	0.0137	0.0196	CbGbCtD
Ifosfamide—CYP3A7—Dexamethasone—psoriasis	0.0134	0.0192	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0134	0.0192	CbGbCtD
Ifosfamide—CYP2C19—Prednisone—psoriasis	0.013	0.0186	CbGbCtD
Ifosfamide—CYP2B6—Dexamethasone—psoriasis	0.0128	0.0183	CbGbCtD
Ifosfamide—CYP2C19—Cyclosporine—psoriasis	0.0123	0.0177	CbGbCtD
Ifosfamide—CYP2C9—Cyclosporine—psoriasis	0.0103	0.0147	CbGbCtD
Ifosfamide—CYP3A5—Dexamethasone—psoriasis	0.0101	0.0144	CbGbCtD
Ifosfamide—CYP2C8—Dexamethasone—psoriasis	0.00969	0.0139	CbGbCtD
Ifosfamide—CYP3A4—Cholecalciferol—psoriasis	0.00909	0.013	CbGbCtD
Ifosfamide—CYP2C19—Dexamethasone—psoriasis	0.00813	0.0116	CbGbCtD
Ifosfamide—CYP3A4—Mycophenolate mofetil—psoriasis	0.00788	0.0113	CbGbCtD
Ifosfamide—CYP3A4—Triamcinolone—psoriasis	0.00788	0.0113	CbGbCtD
Ifosfamide—CYP2C9—Dexamethasone—psoriasis	0.00676	0.00967	CbGbCtD
Ifosfamide—CYP3A4—Betamethasone—psoriasis	0.00676	0.00967	CbGbCtD
Ifosfamide—CYP3A4—Prednisolone—psoriasis	0.00667	0.00954	CbGbCtD
Ifosfamide—CYP3A4—Hydrocortisone—psoriasis	0.00632	0.00904	CbGbCtD
Ifosfamide—CYP3A4—Prednisone—psoriasis	0.0063	0.00901	CbGbCtD
Ifosfamide—CYP3A4—Cyclosporine—psoriasis	0.00597	0.00854	CbGbCtD
Ifosfamide—CYP3A4—Dexamethasone—psoriasis	0.00393	0.00562	CbGbCtD
Ifosfamide—CYP2C18—Xenobiotics—CYP2S1—psoriasis	0.0026	0.0555	CbGpPWpGaD
Ifosfamide—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00255	0.0545	CbGpPWpGaD
Ifosfamide—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00206	0.044	CbGpPWpGaD
Ifosfamide—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00174	0.0373	CbGpPWpGaD
Ifosfamide—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00173	0.0369	CbGpPWpGaD
Ifosfamide—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00158	0.0338	CbGpPWpGaD
Ifosfamide—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00156	0.0333	CbGpPWpGaD
Ifosfamide—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00142	0.0303	CbGpPWpGaD
Ifosfamide—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00128	0.0273	CbGpPWpGaD
Ifosfamide—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.00125	0.0267	CbGpPWpGaD
Ifosfamide—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00108	0.0231	CbGpPWpGaD
Ifosfamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00108	0.023	CbGpPWpGaD
Ifosfamide—CYP2C18—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00106	0.0227	CbGpPWpGaD
Ifosfamide—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000965	0.0206	CbGpPWpGaD
Ifosfamide—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00088	0.0188	CbGpPWpGaD
Ifosfamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000875	0.0187	CbGpPWpGaD
Ifosfamide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000717	0.0153	CbGpPWpGaD
Ifosfamide—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000708	0.0151	CbGpPWpGaD
Ifosfamide—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000657	0.014	CbGpPWpGaD
Ifosfamide—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000649	0.0139	CbGpPWpGaD
Ifosfamide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000581	0.0124	CbGpPWpGaD
Ifosfamide—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00058	0.0124	CbGpPWpGaD
Ifosfamide—PTGS1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000564	0.012	CbGpPWpGaD
Ifosfamide—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000533	0.0114	CbGpPWpGaD
Ifosfamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00053	0.0113	CbGpPWpGaD
Ifosfamide—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000523	0.0112	CbGpPWpGaD
Ifosfamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000518	0.0111	CbGpPWpGaD
Ifosfamide—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000512	0.0109	CbGpPWpGaD
Ifosfamide—CYP2C18—Biological oxidations—CYP2S1—psoriasis	0.000465	0.00992	CbGpPWpGaD
Ifosfamide—CYP2C18—Metapathway biotransformation—CYP2S1—psoriasis	0.000458	0.00978	CbGpPWpGaD
Ifosfamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000449	0.00959	CbGpPWpGaD
Ifosfamide—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000443	0.00946	CbGpPWpGaD
Ifosfamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00043	0.00918	CbGpPWpGaD
Ifosfamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00042	0.00897	CbGpPWpGaD
Ifosfamide—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000416	0.00888	CbGpPWpGaD
Ifosfamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000412	0.00879	CbGpPWpGaD
Ifosfamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000401	0.00856	CbGpPWpGaD
Ifosfamide—CYP2C18—Tryptophan metabolism—CAT—psoriasis	0.000401	0.00856	CbGpPWpGaD
Ifosfamide—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000396	0.00845	CbGpPWpGaD
Ifosfamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000365	0.0078	CbGpPWpGaD
Ifosfamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000364	0.00777	CbGpPWpGaD
Ifosfamide—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000361	0.0077	CbGpPWpGaD
Ifosfamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000325	0.00694	CbGpPWpGaD
Ifosfamide—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000309	0.00659	CbGpPWpGaD
Ifosfamide—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000305	0.0065	CbGpPWpGaD
Ifosfamide—PTGS1—Biological oxidations—CYP2S1—psoriasis	0.000299	0.00639	CbGpPWpGaD
Ifosfamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000296	0.00633	CbGpPWpGaD
Ifosfamide—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000283	0.00604	CbGpPWpGaD
Ifosfamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000273	0.00583	CbGpPWpGaD
Ifosfamide—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	0.000271	0.00578	CbGpPWpGaD
Ifosfamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000263	0.00561	CbGpPWpGaD
Ifosfamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000244	0.0052	CbGpPWpGaD
Ifosfamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000241	0.00515	CbGpPWpGaD
Ifosfamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000238	0.00509	CbGpPWpGaD
Ifosfamide—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000238	0.00508	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000228	0.00488	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000225	0.00481	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000223	0.00477	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.00022	0.0047	CbGpPWpGaD
Ifosfamide—CYP2C18—FOXA1 transcription factor network—JUN—psoriasis	0.000199	0.00426	CbGpPWpGaD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000195	0.00417	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000193	0.00413	CbGpPWpGaD
Ifosfamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000193	0.00412	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000191	0.00407	CbGpPWpGaD
Ifosfamide—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	0.000188	0.00402	CbGpPWpGaD
Ifosfamide—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000173	0.00369	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.00017	0.00363	CbGpPWpGaD
Ifosfamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00017	0.00363	CbGpPWpGaD
Ifosfamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000168	0.00358	CbGpPWpGaD
Ifosfamide—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000167	0.00357	CbGpPWpGaD
Ifosfamide—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000158	0.00337	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000157	0.00336	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000155	0.00331	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	0.000154	0.00328	CbGpPWpGaD
Ifosfamide—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	0.000152	0.00324	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	0.000122	0.00261	CbGpPWpGaD
Ifosfamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000117	0.0025	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	0.000112	0.0024	CbGpPWpGaD
Ifosfamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000111	0.00236	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000104	0.00222	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000102	0.00219	CbGpPWpGaD
Ifosfamide—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000101	0.00216	CbGpPWpGaD
Ifosfamide—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	9.95e-05	0.00213	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NDUFA5—psoriasis	9.34e-05	0.002	CbGpPWpGaD
Ifosfamide—CYP3A4—Tryptophan metabolism—CAT—psoriasis	8.95e-05	0.00191	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	8.54e-05	0.00182	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP2S1—psoriasis	7.94e-05	0.0017	CbGpPWpGaD
Ifosfamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.72e-05	0.00165	CbGpPWpGaD
Ifosfamide—Hypotension—Hydrocortisone—psoriasis	7.2e-05	0.000283	CcSEcCtD
Ifosfamide—Haematuria—Methotrexate—psoriasis	7.16e-05	0.000282	CcSEcCtD
Ifosfamide—Feeling abnormal—Cyclosporine—psoriasis	7.14e-05	0.000281	CcSEcCtD
Ifosfamide—Alopecia—Prednisone—psoriasis	7.13e-05	0.00028	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	7.1e-05	0.00152	CbGpPWpGaD
Ifosfamide—Hepatobiliary disease—Methotrexate—psoriasis	7.1e-05	0.000279	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Cyclosporine—psoriasis	7.09e-05	0.000279	CcSEcCtD
Ifosfamide—Dizziness—Mycophenolic acid—psoriasis	7.08e-05	0.000279	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisolone—psoriasis	7.08e-05	0.000279	CcSEcCtD
Ifosfamide—Mental disorder—Prednisone—psoriasis	7.07e-05	0.000278	CcSEcCtD
Ifosfamide—Malnutrition—Prednisone—psoriasis	7.02e-05	0.000276	CcSEcCtD
Ifosfamide—Erythema—Prednisone—psoriasis	7.02e-05	0.000276	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	7.02e-05	0.000276	CcSEcCtD
Ifosfamide—Hyperhidrosis—Triamcinolone—psoriasis	7.01e-05	0.000276	CcSEcCtD
Ifosfamide—Agranulocytosis—Methotrexate—psoriasis	7.01e-05	0.000276	CcSEcCtD
Ifosfamide—Convulsion—Betamethasone—psoriasis	6.99e-05	0.000275	CcSEcCtD
Ifosfamide—Convulsion—Dexamethasone—psoriasis	6.99e-05	0.000275	CcSEcCtD
Ifosfamide—Feeling abnormal—Mycophenolate mofetil—psoriasis	6.97e-05	0.000274	CcSEcCtD
Ifosfamide—Hypertension—Dexamethasone—psoriasis	6.96e-05	0.000274	CcSEcCtD
Ifosfamide—Hypertension—Betamethasone—psoriasis	6.96e-05	0.000274	CcSEcCtD
Ifosfamide—Paraesthesia—Hydrocortisone—psoriasis	6.92e-05	0.000272	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	6.91e-05	0.000272	CcSEcCtD
Ifosfamide—Urticaria—Cyclosporine—psoriasis	6.88e-05	0.000271	CcSEcCtD
Ifosfamide—Myalgia—Dexamethasone—psoriasis	6.86e-05	0.00027	CcSEcCtD
Ifosfamide—Myalgia—Betamethasone—psoriasis	6.86e-05	0.00027	CcSEcCtD
Ifosfamide—Body temperature increased—Cyclosporine—psoriasis	6.85e-05	0.000269	CcSEcCtD
Ifosfamide—Abdominal pain—Cyclosporine—psoriasis	6.85e-05	0.000269	CcSEcCtD
Ifosfamide—Vomiting—Mycophenolic acid—psoriasis	6.81e-05	0.000268	CcSEcCtD
Ifosfamide—Discomfort—Betamethasone—psoriasis	6.78e-05	0.000267	CcSEcCtD
Ifosfamide—Discomfort—Dexamethasone—psoriasis	6.78e-05	0.000267	CcSEcCtD
Ifosfamide—Haemoglobin—Methotrexate—psoriasis	6.78e-05	0.000266	CcSEcCtD
Ifosfamide—Rash—Mycophenolic acid—psoriasis	6.75e-05	0.000266	CcSEcCtD
Ifosfamide—Dermatitis—Mycophenolic acid—psoriasis	6.75e-05	0.000265	CcSEcCtD
Ifosfamide—Pain—Prednisolone—psoriasis	6.74e-05	0.000265	CcSEcCtD
Ifosfamide—Hepatitis—Methotrexate—psoriasis	6.74e-05	0.000265	CcSEcCtD
Ifosfamide—Haemorrhage—Methotrexate—psoriasis	6.74e-05	0.000265	CcSEcCtD
Ifosfamide—Urticaria—Mycophenolate mofetil—psoriasis	6.72e-05	0.000264	CcSEcCtD
Ifosfamide—Decreased appetite—Hydrocortisone—psoriasis	6.7e-05	0.000263	CcSEcCtD
Ifosfamide—Body temperature increased—Mycophenolate mofetil—psoriasis	6.68e-05	0.000263	CcSEcCtD
Ifosfamide—Abdominal pain—Mycophenolate mofetil—psoriasis	6.68e-05	0.000263	CcSEcCtD
Ifosfamide—Urinary tract disorder—Methotrexate—psoriasis	6.66e-05	0.000262	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.65e-05	0.000262	CcSEcCtD
Ifosfamide—Fatigue—Hydrocortisone—psoriasis	6.64e-05	0.000261	CcSEcCtD
Ifosfamide—Vision blurred—Prednisone—psoriasis	6.62e-05	0.00026	CcSEcCtD
Ifosfamide—Urethral disorder—Methotrexate—psoriasis	6.61e-05	0.00026	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.61e-05	0.00026	CcSEcCtD
Ifosfamide—Pain—Hydrocortisone—psoriasis	6.59e-05	0.000259	CcSEcCtD
Ifosfamide—Oedema—Dexamethasone—psoriasis	6.58e-05	0.000259	CcSEcCtD
Ifosfamide—Anaphylactic shock—Dexamethasone—psoriasis	6.58e-05	0.000259	CcSEcCtD
Ifosfamide—Oedema—Betamethasone—psoriasis	6.58e-05	0.000259	CcSEcCtD
Ifosfamide—Anaphylactic shock—Betamethasone—psoriasis	6.58e-05	0.000259	CcSEcCtD
Ifosfamide—Infection—Dexamethasone—psoriasis	6.54e-05	0.000257	CcSEcCtD
Ifosfamide—Infection—Betamethasone—psoriasis	6.54e-05	0.000257	CcSEcCtD
Ifosfamide—Ill-defined disorder—Prednisone—psoriasis	6.52e-05	0.000256	CcSEcCtD
Ifosfamide—Paraesthesia—Triamcinolone—psoriasis	6.51e-05	0.000256	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisolone—psoriasis	6.5e-05	0.000256	CcSEcCtD
Ifosfamide—Visual impairment—Methotrexate—psoriasis	6.5e-05	0.000256	CcSEcCtD
Ifosfamide—Anaemia—Prednisone—psoriasis	6.49e-05	0.000255	CcSEcCtD
Ifosfamide—Dyspnoea—Triamcinolone—psoriasis	6.47e-05	0.000254	CcSEcCtD
Ifosfamide—Nervous system disorder—Betamethasone—psoriasis	6.45e-05	0.000254	CcSEcCtD
Ifosfamide—Nervous system disorder—Dexamethasone—psoriasis	6.45e-05	0.000254	CcSEcCtD
Ifosfamide—Agitation—Prednisone—psoriasis	6.45e-05	0.000254	CcSEcCtD
Ifosfamide—Thrombocytopenia—Betamethasone—psoriasis	6.44e-05	0.000253	CcSEcCtD
Ifosfamide—Thrombocytopenia—Dexamethasone—psoriasis	6.44e-05	0.000253	CcSEcCtD
Ifosfamide—Angioedema—Prednisone—psoriasis	6.42e-05	0.000252	CcSEcCtD
Ifosfamide—Hypersensitivity—Cyclosporine—psoriasis	6.39e-05	0.000251	CcSEcCtD
Ifosfamide—Erythema multiforme—Methotrexate—psoriasis	6.37e-05	0.000251	CcSEcCtD
Ifosfamide—Nausea—Mycophenolic acid—psoriasis	6.36e-05	0.00025	CcSEcCtD
Ifosfamide—Hyperhidrosis—Dexamethasone—psoriasis	6.36e-05	0.00025	CcSEcCtD
Ifosfamide—Hyperhidrosis—Betamethasone—psoriasis	6.36e-05	0.00025	CcSEcCtD
Ifosfamide—Feeling abnormal—Hydrocortisone—psoriasis	6.35e-05	0.00025	CcSEcCtD
Ifosfamide—Malaise—Prednisone—psoriasis	6.33e-05	0.000249	CcSEcCtD
Ifosfamide—Vertigo—Prednisone—psoriasis	6.31e-05	0.000248	CcSEcCtD
Ifosfamide—Eye disorder—Methotrexate—psoriasis	6.3e-05	0.000248	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Hydrocortisone—psoriasis	6.3e-05	0.000248	CcSEcCtD
Ifosfamide—Tinnitus—Methotrexate—psoriasis	6.29e-05	0.000247	CcSEcCtD
Ifosfamide—Anorexia—Dexamethasone—psoriasis	6.27e-05	0.000247	CcSEcCtD
Ifosfamide—Anorexia—Betamethasone—psoriasis	6.27e-05	0.000247	CcSEcCtD
Ifosfamide—Urticaria—Prednisolone—psoriasis	6.26e-05	0.000246	CcSEcCtD
Ifosfamide—Cardiac disorder—Methotrexate—psoriasis	6.26e-05	0.000246	CcSEcCtD
Ifosfamide—Fatigue—Triamcinolone—psoriasis	6.25e-05	0.000246	CcSEcCtD
Ifosfamide—Hypersensitivity—Mycophenolate mofetil—psoriasis	6.23e-05	0.000245	CcSEcCtD
Ifosfamide—Asthenia—Cyclosporine—psoriasis	6.22e-05	0.000245	CcSEcCtD
Ifosfamide—CYP3A7—Metabolism—NDUFA5—psoriasis	6.21e-05	0.00133	CbGpPWpGaD
Ifosfamide—Pain—Triamcinolone—psoriasis	6.2e-05	0.000244	CcSEcCtD
Ifosfamide—Hypotension—Betamethasone—psoriasis	6.15e-05	0.000242	CcSEcCtD
Ifosfamide—Hypotension—Dexamethasone—psoriasis	6.15e-05	0.000242	CcSEcCtD
Ifosfamide—Pruritus—Cyclosporine—psoriasis	6.13e-05	0.000241	CcSEcCtD
Ifosfamide—Urticaria—Hydrocortisone—psoriasis	6.12e-05	0.000241	CcSEcCtD
Ifosfamide—Angiopathy—Methotrexate—psoriasis	6.12e-05	0.000241	CcSEcCtD
Ifosfamide—Immune system disorder—Methotrexate—psoriasis	6.09e-05	0.000239	CcSEcCtD
Ifosfamide—Body temperature increased—Hydrocortisone—psoriasis	6.09e-05	0.000239	CcSEcCtD
Ifosfamide—Abdominal pain—Hydrocortisone—psoriasis	6.09e-05	0.000239	CcSEcCtD
Ifosfamide—Convulsion—Prednisone—psoriasis	6.08e-05	0.000239	CcSEcCtD
Ifosfamide—Mediastinal disorder—Methotrexate—psoriasis	6.08e-05	0.000239	CcSEcCtD
Ifosfamide—Asthenia—Mycophenolate mofetil—psoriasis	6.07e-05	0.000239	CcSEcCtD
Ifosfamide—Hypertension—Prednisone—psoriasis	6.06e-05	0.000238	CcSEcCtD
Ifosfamide—Chills—Methotrexate—psoriasis	6.05e-05	0.000238	CcSEcCtD
Ifosfamide—PTGS1—Metabolism—NDUFA5—psoriasis	6.02e-05	0.00129	CbGpPWpGaD
Ifosfamide—Musculoskeletal discomfort—Betamethasone—psoriasis	6e-05	0.000236	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Dexamethasone—psoriasis	6e-05	0.000236	CcSEcCtD
Ifosfamide—Pruritus—Mycophenolate mofetil—psoriasis	5.98e-05	0.000235	CcSEcCtD
Ifosfamide—Myalgia—Prednisone—psoriasis	5.98e-05	0.000235	CcSEcCtD
Ifosfamide—Arthralgia—Prednisone—psoriasis	5.98e-05	0.000235	CcSEcCtD
Ifosfamide—Feeling abnormal—Triamcinolone—psoriasis	5.98e-05	0.000235	CcSEcCtD
Ifosfamide—Alopecia—Methotrexate—psoriasis	5.96e-05	0.000234	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.94e-05	0.000233	CcSEcCtD
Ifosfamide—Diarrhoea—Cyclosporine—psoriasis	5.93e-05	0.000233	CcSEcCtD
Ifosfamide—Paraesthesia—Dexamethasone—psoriasis	5.91e-05	0.000232	CcSEcCtD
Ifosfamide—Paraesthesia—Betamethasone—psoriasis	5.91e-05	0.000232	CcSEcCtD
Ifosfamide—Discomfort—Prednisone—psoriasis	5.91e-05	0.000232	CcSEcCtD
Ifosfamide—Mental disorder—Methotrexate—psoriasis	5.91e-05	0.000232	CcSEcCtD
Ifosfamide—Erythema—Methotrexate—psoriasis	5.87e-05	0.000231	CcSEcCtD
Ifosfamide—Malnutrition—Methotrexate—psoriasis	5.87e-05	0.000231	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisolone—psoriasis	5.81e-05	0.000229	CcSEcCtD
Ifosfamide—Diarrhoea—Mycophenolate mofetil—psoriasis	5.78e-05	0.000228	CcSEcCtD
Ifosfamide—Urticaria—Triamcinolone—psoriasis	5.76e-05	0.000227	CcSEcCtD
Ifosfamide—Body temperature increased—Triamcinolone—psoriasis	5.73e-05	0.000225	CcSEcCtD
Ifosfamide—Dizziness—Cyclosporine—psoriasis	5.73e-05	0.000225	CcSEcCtD
Ifosfamide—Oedema—Prednisone—psoriasis	5.73e-05	0.000225	CcSEcCtD
Ifosfamide—Anaphylactic shock—Prednisone—psoriasis	5.73e-05	0.000225	CcSEcCtD
Ifosfamide—Decreased appetite—Dexamethasone—psoriasis	5.72e-05	0.000225	CcSEcCtD
Ifosfamide—Decreased appetite—Betamethasone—psoriasis	5.72e-05	0.000225	CcSEcCtD
Ifosfamide—Infection—Prednisone—psoriasis	5.69e-05	0.000224	CcSEcCtD
Ifosfamide—CYP2A6—Metabolism—NDUFA5—psoriasis	5.69e-05	0.00122	CbGpPWpGaD
Ifosfamide—Gastrointestinal disorder—Betamethasone—psoriasis	5.68e-05	0.000223	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Dexamethasone—psoriasis	5.68e-05	0.000223	CcSEcCtD
Ifosfamide—Hypersensitivity—Hydrocortisone—psoriasis	5.67e-05	0.000223	CcSEcCtD
Ifosfamide—Fatigue—Betamethasone—psoriasis	5.67e-05	0.000223	CcSEcCtD
Ifosfamide—Fatigue—Dexamethasone—psoriasis	5.67e-05	0.000223	CcSEcCtD
Ifosfamide—Pain—Dexamethasone—psoriasis	5.63e-05	0.000221	CcSEcCtD
Ifosfamide—Pain—Betamethasone—psoriasis	5.63e-05	0.000221	CcSEcCtD
Ifosfamide—Nervous system disorder—Prednisone—psoriasis	5.62e-05	0.000221	CcSEcCtD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.61e-05	0.0012	CbGpPWpGaD
Ifosfamide—Dizziness—Mycophenolate mofetil—psoriasis	5.59e-05	0.00022	CcSEcCtD
Ifosfamide—Skin disorder—Prednisone—psoriasis	5.57e-05	0.000219	CcSEcCtD
Ifosfamide—Hyperhidrosis—Prednisone—psoriasis	5.54e-05	0.000218	CcSEcCtD
Ifosfamide—Vision blurred—Methotrexate—psoriasis	5.53e-05	0.000218	CcSEcCtD
Ifosfamide—Asthenia—Hydrocortisone—psoriasis	5.53e-05	0.000217	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	5.52e-05	0.00118	CbGpPWpGaD
Ifosfamide—Vomiting—Cyclosporine—psoriasis	5.51e-05	0.000217	CcSEcCtD
Ifosfamide—Rash—Cyclosporine—psoriasis	5.46e-05	0.000215	CcSEcCtD
Ifosfamide—Anorexia—Prednisone—psoriasis	5.46e-05	0.000215	CcSEcCtD
Ifosfamide—Dermatitis—Cyclosporine—psoriasis	5.46e-05	0.000215	CcSEcCtD
Ifosfamide—Pruritus—Hydrocortisone—psoriasis	5.45e-05	0.000214	CcSEcCtD
Ifosfamide—Ill-defined disorder—Methotrexate—psoriasis	5.44e-05	0.000214	CcSEcCtD
Ifosfamide—Anaemia—Methotrexate—psoriasis	5.42e-05	0.000213	CcSEcCtD
Ifosfamide—Feeling abnormal—Betamethasone—psoriasis	5.42e-05	0.000213	CcSEcCtD
Ifosfamide—Feeling abnormal—Dexamethasone—psoriasis	5.42e-05	0.000213	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dexamethasone—psoriasis	5.38e-05	0.000212	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Betamethasone—psoriasis	5.38e-05	0.000212	CcSEcCtD
Ifosfamide—Vomiting—Mycophenolate mofetil—psoriasis	5.38e-05	0.000211	CcSEcCtD
Ifosfamide—Hypersensitivity—Triamcinolone—psoriasis	5.34e-05	0.00021	CcSEcCtD
Ifosfamide—Rash—Mycophenolate mofetil—psoriasis	5.33e-05	0.00021	CcSEcCtD
Ifosfamide—Dermatitis—Mycophenolate mofetil—psoriasis	5.33e-05	0.000209	CcSEcCtD
Ifosfamide—Malaise—Methotrexate—psoriasis	5.29e-05	0.000208	CcSEcCtD
Ifosfamide—CYP3A7—Metabolism—CYP2S1—psoriasis	5.28e-05	0.00113	CbGpPWpGaD
Ifosfamide—Vertigo—Methotrexate—psoriasis	5.27e-05	0.000207	CcSEcCtD
Ifosfamide—Diarrhoea—Hydrocortisone—psoriasis	5.27e-05	0.000207	CcSEcCtD
Ifosfamide—Leukopenia—Methotrexate—psoriasis	5.25e-05	0.000207	CcSEcCtD
Ifosfamide—Urticaria—Betamethasone—psoriasis	5.23e-05	0.000206	CcSEcCtD
Ifosfamide—Urticaria—Dexamethasone—psoriasis	5.23e-05	0.000206	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Prednisone—psoriasis	5.22e-05	0.000205	CcSEcCtD
Ifosfamide—Dizziness—Prednisolone—psoriasis	5.21e-05	0.000205	CcSEcCtD
Ifosfamide—Asthenia—Triamcinolone—psoriasis	5.2e-05	0.000205	CcSEcCtD
Ifosfamide—Body temperature increased—Dexamethasone—psoriasis	5.2e-05	0.000205	CcSEcCtD
Ifosfamide—Abdominal pain—Dexamethasone—psoriasis	5.2e-05	0.000205	CcSEcCtD
Ifosfamide—Body temperature increased—Betamethasone—psoriasis	5.2e-05	0.000205	CcSEcCtD
Ifosfamide—Abdominal pain—Betamethasone—psoriasis	5.2e-05	0.000205	CcSEcCtD
Ifosfamide—Nausea—Cyclosporine—psoriasis	5.15e-05	0.000202	CcSEcCtD
Ifosfamide—Paraesthesia—Prednisone—psoriasis	5.15e-05	0.000202	CcSEcCtD
Ifosfamide—Pruritus—Triamcinolone—psoriasis	5.13e-05	0.000202	CcSEcCtD
Ifosfamide—Cough—Methotrexate—psoriasis	5.12e-05	0.000201	CcSEcCtD
Ifosfamide—PTGS1—Metabolism—CYP2S1—psoriasis	5.12e-05	0.00109	CbGpPWpGaD
Ifosfamide—Dizziness—Hydrocortisone—psoriasis	5.09e-05	0.0002	CcSEcCtD
Ifosfamide—Convulsion—Methotrexate—psoriasis	5.08e-05	0.0002	CcSEcCtD
Ifosfamide—Nausea—Mycophenolate mofetil—psoriasis	5.02e-05	0.000198	CcSEcCtD
Ifosfamide—Arthralgia—Methotrexate—psoriasis	5e-05	0.000196	CcSEcCtD
Ifosfamide—Myalgia—Methotrexate—psoriasis	5e-05	0.000196	CcSEcCtD
Ifosfamide—Chest pain—Methotrexate—psoriasis	5e-05	0.000196	CcSEcCtD
Ifosfamide—Decreased appetite—Prednisone—psoriasis	4.98e-05	0.000196	CcSEcCtD
Ifosfamide—Rash—Prednisolone—psoriasis	4.97e-05	0.000196	CcSEcCtD
Ifosfamide—Dermatitis—Prednisolone—psoriasis	4.97e-05	0.000195	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.96e-05	0.000195	CcSEcCtD
Ifosfamide—Fatigue—Prednisone—psoriasis	4.94e-05	0.000194	CcSEcCtD
Ifosfamide—Discomfort—Methotrexate—psoriasis	4.94e-05	0.000194	CcSEcCtD
Ifosfamide—Constipation—Prednisone—psoriasis	4.9e-05	0.000193	CcSEcCtD
Ifosfamide—Vomiting—Hydrocortisone—psoriasis	4.9e-05	0.000193	CcSEcCtD
Ifosfamide—Rash—Hydrocortisone—psoriasis	4.86e-05	0.000191	CcSEcCtD
Ifosfamide—Dermatitis—Hydrocortisone—psoriasis	4.85e-05	0.000191	CcSEcCtD
Ifosfamide—CYP2A6—Metabolism—CYP2S1—psoriasis	4.84e-05	0.00103	CbGpPWpGaD
Ifosfamide—Confusional state—Methotrexate—psoriasis	4.83e-05	0.00019	CcSEcCtD
Ifosfamide—Dizziness—Triamcinolone—psoriasis	4.8e-05	0.000189	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methotrexate—psoriasis	4.79e-05	0.000188	CcSEcCtD
Ifosfamide—Infection—Methotrexate—psoriasis	4.76e-05	0.000187	CcSEcCtD
Ifosfamide—Feeling abnormal—Prednisone—psoriasis	4.72e-05	0.000186	CcSEcCtD
Ifosfamide—Asthenia—Dexamethasone—psoriasis	4.72e-05	0.000186	CcSEcCtD
Ifosfamide—Asthenia—Betamethasone—psoriasis	4.72e-05	0.000186	CcSEcCtD
Ifosfamide—Nervous system disorder—Methotrexate—psoriasis	4.7e-05	0.000185	CcSEcCtD
Ifosfamide—Thrombocytopenia—Methotrexate—psoriasis	4.69e-05	0.000184	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Prednisone—psoriasis	4.69e-05	0.000184	CcSEcCtD
Ifosfamide—Nausea—Prednisolone—psoriasis	4.68e-05	0.000184	CcSEcCtD
Ifosfamide—Pruritus—Betamethasone—psoriasis	4.66e-05	0.000183	CcSEcCtD
Ifosfamide—Pruritus—Dexamethasone—psoriasis	4.66e-05	0.000183	CcSEcCtD
Ifosfamide—Skin disorder—Methotrexate—psoriasis	4.65e-05	0.000183	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methotrexate—psoriasis	4.63e-05	0.000182	CcSEcCtD
Ifosfamide—Vomiting—Triamcinolone—psoriasis	4.61e-05	0.000181	CcSEcCtD
Ifosfamide—CYP2B6—Metabolism—NDUFA5—psoriasis	4.59e-05	0.000981	CbGpPWpGaD
Ifosfamide—Nausea—Hydrocortisone—psoriasis	4.57e-05	0.00018	CcSEcCtD
Ifosfamide—Rash—Triamcinolone—psoriasis	4.57e-05	0.00018	CcSEcCtD
Ifosfamide—Dermatitis—Triamcinolone—psoriasis	4.57e-05	0.00018	CcSEcCtD
Ifosfamide—Anorexia—Methotrexate—psoriasis	4.57e-05	0.00018	CcSEcCtD
Ifosfamide—Urticaria—Prednisone—psoriasis	4.55e-05	0.000179	CcSEcCtD
Ifosfamide—Abdominal pain—Prednisone—psoriasis	4.53e-05	0.000178	CcSEcCtD
Ifosfamide—Body temperature increased—Prednisone—psoriasis	4.53e-05	0.000178	CcSEcCtD
Ifosfamide—Diarrhoea—Betamethasone—psoriasis	4.5e-05	0.000177	CcSEcCtD
Ifosfamide—Diarrhoea—Dexamethasone—psoriasis	4.5e-05	0.000177	CcSEcCtD
Ifosfamide—CYP3A5—Metabolism—NDUFA5—psoriasis	4.49e-05	0.000959	CbGpPWpGaD
Ifosfamide—Hypotension—Methotrexate—psoriasis	4.48e-05	0.000176	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	4.46e-05	0.000952	CbGpPWpGaD
Ifosfamide—Musculoskeletal discomfort—Methotrexate—psoriasis	4.36e-05	0.000172	CcSEcCtD
Ifosfamide—Dizziness—Betamethasone—psoriasis	4.35e-05	0.000171	CcSEcCtD
Ifosfamide—Dizziness—Dexamethasone—psoriasis	4.35e-05	0.000171	CcSEcCtD
Ifosfamide—Nausea—Triamcinolone—psoriasis	4.31e-05	0.000169	CcSEcCtD
Ifosfamide—Paraesthesia—Methotrexate—psoriasis	4.3e-05	0.000169	CcSEcCtD
Ifosfamide—Dyspnoea—Methotrexate—psoriasis	4.27e-05	0.000168	CcSEcCtD
Ifosfamide—Somnolence—Methotrexate—psoriasis	4.26e-05	0.000167	CcSEcCtD
Ifosfamide—Hypersensitivity—Prednisone—psoriasis	4.22e-05	0.000166	CcSEcCtD
Ifosfamide—Vomiting—Betamethasone—psoriasis	4.18e-05	0.000165	CcSEcCtD
Ifosfamide—Vomiting—Dexamethasone—psoriasis	4.18e-05	0.000165	CcSEcCtD
Ifosfamide—Decreased appetite—Methotrexate—psoriasis	4.16e-05	0.000164	CcSEcCtD
Ifosfamide—Rash—Dexamethasone—psoriasis	4.15e-05	0.000163	CcSEcCtD
Ifosfamide—Rash—Betamethasone—psoriasis	4.15e-05	0.000163	CcSEcCtD
Ifosfamide—Dermatitis—Dexamethasone—psoriasis	4.15e-05	0.000163	CcSEcCtD
Ifosfamide—Dermatitis—Betamethasone—psoriasis	4.15e-05	0.000163	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Methotrexate—psoriasis	4.13e-05	0.000163	CcSEcCtD
Ifosfamide—Fatigue—Methotrexate—psoriasis	4.13e-05	0.000162	CcSEcCtD
Ifosfamide—Asthenia—Prednisone—psoriasis	4.11e-05	0.000162	CcSEcCtD
Ifosfamide—Pain—Methotrexate—psoriasis	4.1e-05	0.000161	CcSEcCtD
Ifosfamide—Pruritus—Prednisone—psoriasis	4.05e-05	0.000159	CcSEcCtD
Ifosfamide—Feeling abnormal—Methotrexate—psoriasis	3.95e-05	0.000155	CcSEcCtD
Ifosfamide—Diarrhoea—Prednisone—psoriasis	3.92e-05	0.000154	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methotrexate—psoriasis	3.92e-05	0.000154	CcSEcCtD
Ifosfamide—Nausea—Betamethasone—psoriasis	3.91e-05	0.000154	CcSEcCtD
Ifosfamide—Nausea—Dexamethasone—psoriasis	3.91e-05	0.000154	CcSEcCtD
Ifosfamide—CYP2B6—Metabolism—CYP2S1—psoriasis	3.91e-05	0.000834	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NDUFA5—psoriasis	3.89e-05	0.00083	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CARM1—psoriasis	3.88e-05	0.000828	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP2S1—psoriasis	3.82e-05	0.000815	CbGpPWpGaD
Ifosfamide—Urticaria—Methotrexate—psoriasis	3.8e-05	0.00015	CcSEcCtD
Ifosfamide—Dizziness—Prednisone—psoriasis	3.79e-05	0.000149	CcSEcCtD
Ifosfamide—Abdominal pain—Methotrexate—psoriasis	3.79e-05	0.000149	CcSEcCtD
Ifosfamide—Body temperature increased—Methotrexate—psoriasis	3.79e-05	0.000149	CcSEcCtD
Ifosfamide—Vomiting—Prednisone—psoriasis	3.64e-05	0.000143	CcSEcCtD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.63e-05	0.000774	CbGpPWpGaD
Ifosfamide—Rash—Prednisone—psoriasis	3.61e-05	0.000142	CcSEcCtD
Ifosfamide—Dermatitis—Prednisone—psoriasis	3.61e-05	0.000142	CcSEcCtD
Ifosfamide—Hypersensitivity—Methotrexate—psoriasis	3.53e-05	0.000139	CcSEcCtD
Ifosfamide—CYP2C19—Metabolism—NDUFA5—psoriasis	3.47e-05	0.000741	CbGpPWpGaD
Ifosfamide—Asthenia—Methotrexate—psoriasis	3.44e-05	0.000135	CcSEcCtD
Ifosfamide—Nausea—Prednisone—psoriasis	3.4e-05	0.000134	CcSEcCtD
Ifosfamide—Pruritus—Methotrexate—psoriasis	3.39e-05	0.000133	CcSEcCtD
Ifosfamide—CYP2C8—Metabolism—CYP2S1—psoriasis	3.31e-05	0.000706	CbGpPWpGaD
Ifosfamide—Diarrhoea—Methotrexate—psoriasis	3.28e-05	0.000129	CcSEcCtD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.24e-05	0.000691	CbGpPWpGaD
Ifosfamide—Dizziness—Methotrexate—psoriasis	3.17e-05	0.000125	CcSEcCtD
Ifosfamide—CYP2C9—Metabolism—NDUFA5—psoriasis	3.17e-05	0.000676	CbGpPWpGaD
Ifosfamide—Vomiting—Methotrexate—psoriasis	3.05e-05	0.00012	CcSEcCtD
Ifosfamide—Rash—Methotrexate—psoriasis	3.02e-05	0.000119	CcSEcCtD
Ifosfamide—Dermatitis—Methotrexate—psoriasis	3.02e-05	0.000119	CcSEcCtD
Ifosfamide—CYP2C19—Metabolism—CYP2S1—psoriasis	2.95e-05	0.00063	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.95e-05	0.00063	CbGpPWpGaD
Ifosfamide—Nausea—Methotrexate—psoriasis	2.84e-05	0.000112	CcSEcCtD
Ifosfamide—CYP2C9—Metabolism—CYP2S1—psoriasis	2.69e-05	0.000575	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.68e-05	0.000573	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CARM1—psoriasis	2.58e-05	0.000551	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CARM1—psoriasis	2.5e-05	0.000534	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CAT—psoriasis	2.39e-05	0.00051	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CARM1—psoriasis	2.36e-05	0.000505	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.34e-05	0.000499	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NDUFA5—psoriasis	2.09e-05	0.000446	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CARM1—psoriasis	1.91e-05	0.000407	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CARM1—psoriasis	1.86e-05	0.000398	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—APOE—psoriasis	1.85e-05	0.000396	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2S1—psoriasis	1.77e-05	0.000379	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.73e-05	0.00037	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PPARG—psoriasis	1.61e-05	0.000345	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CARM1—psoriasis	1.61e-05	0.000345	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CAT—psoriasis	1.59e-05	0.000339	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.55e-05	0.00033	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CAT—psoriasis	1.54e-05	0.000328	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.51e-05	0.000322	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CAT—psoriasis	1.45e-05	0.000311	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CARM1—psoriasis	1.44e-05	0.000308	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.41e-05	0.000301	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.35e-05	0.000288	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CARM1—psoriasis	1.31e-05	0.000281	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—APOE—psoriasis	1.23e-05	0.000263	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.23e-05	0.000262	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APOE—psoriasis	1.19e-05	0.000255	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CAT—psoriasis	1.17e-05	0.000251	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CAT—psoriasis	1.15e-05	0.000245	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APOE—psoriasis	1.13e-05	0.000241	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARG—psoriasis	1.07e-05	0.000229	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARG—psoriasis	1.04e-05	0.000222	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CAT—psoriasis	9.93e-06	0.000212	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARG—psoriasis	9.84e-06	0.00021	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—APOE—psoriasis	9.12e-06	0.000195	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOE—psoriasis	8.91e-06	0.00019	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CAT—psoriasis	8.87e-06	0.000189	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CARM1—psoriasis	8.67e-06	0.000185	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CAT—psoriasis	8.08e-06	0.000173	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARG—psoriasis	7.94e-06	0.00017	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARG—psoriasis	7.76e-06	0.000166	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOE—psoriasis	7.72e-06	0.000165	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOE—psoriasis	6.89e-06	0.000147	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARG—psoriasis	6.72e-06	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOE—psoriasis	6.28e-06	0.000134	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARG—psoriasis	6e-06	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARG—psoriasis	5.47e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CAT—psoriasis	5.33e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOE—psoriasis	4.14e-06	8.85e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARG—psoriasis	3.61e-06	7.7e-05	CbGpPWpGaD
